Search by Drug Name or NDC

    NDC 72606-0040-05 Adalimumab 80 mg/.8mL Details

    Adalimumab 80 mg/.8mL

    Adalimumab is a SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by CELLTRION USA, Inc.. The primary component is ADALIMUMAB.

    Product Information

    NDC 72606-0040
    Product ID 72606-040_844d5d61-baed-44ee-afc2-5dd8174c54ca
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Adalimumab
    Proprietary Name Suffix n/a
    Non-Proprietary Name adalimumab-aaty
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 80
    Active Ingredient Units mg/.8mL
    Substance Name ADALIMUMAB
    Labeler Name CELLTRION USA, Inc.
    Pharmaceutical Class Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761219
    Listing Certified Through 2024-12-31

    Package

    NDC 72606-0040-05 (72606004005)

    NDC Package Code 72606-040-05
    Billing NDC 72606004005
    Package 2 SYRINGE, GLASS in 1 CARTON (72606-040-05) / .8 mL in 1 SYRINGE, GLASS
    Marketing Start Date 2023-11-30
    NDC Exclude Flag N
    Pricing Information N/A